GoAI
Get started
Lucyd, Inc logo

Lucyd, Inc

LUCY

NASDAQHealthcareMedical - Instruments & Supplies

Open in GoAI

Previous close

$0.6839

−$0.0006 · -0.09%

Aug 21, 4:00 PM ET

Pre-market

$0.6839

$0.00 · 0.00%

Aug 24, 4:00 AM ET

LUCY company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

51

Fair Value

Momentum

53

Neutral

Sentiment

55

Mixed

Risk resilience

16

Extreme Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names. The company also provides Lucyd app for unlimited ChatGPT interactions and tech support. It sells its products through e-commerce and a network of retail stores of resellers. The company was formerly known as Innovative Eyewear, Inc. and changed its name to Lucyd, Inc in October 2025. Lucyd, Inc was founded in 2019 and is headquartered in North Miami, Florida.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
US
CEO
Harrison Reed Gross
Listed since
Aug 15, 2022
Employees
13

Market position

Day range

Current $0.6839

52-week range

Current $0.6839

Open
$0.6841
Previous close
$0.6845
Volume
87.68K
0.02× average
Average volume
4.44M
Average daily volume
Market cap
4.31M USD
Beta
2.72
Market reference 1
50-day average
$0.8035
-14.88% below average
200-day average
$1.1083
-38.29% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
-2.53M USD
P/E (TTM)
-0.51×
P/B (TTM)
0.63×
P/S (TTM)
1.26×
EV / EBITDA
0.34×
Earnings yield
-190.84%
Free cash flow yield
-189.17%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
22.79%
Operating margin
-249.03%
Net margin
-225.28%
Return on equity
-83.73%
Return on assets
-74.86%
Return on invested capital
-93.41%

Financial health

Debt / equity
0.01×
Current ratio
9.03×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends110%-243%-596%-949%Gross margin, FY2021: 21.47%Gross margin, FY2022: -8.53%Gross margin, FY2023: -10.35%Gross margin, FY2024: 13.15%Gross margin, FY2025: 21.32%Operating margin, FY2021: -464.05%Operating margin, FY2022: -845.22%Operating margin, FY2023: -594.85%Operating margin, FY2024: -484.20%Operating margin, FY2025: -319.16%Net margin, FY2021: -469.76%Net margin, FY2022: -861.16%Net margin, FY2023: -578.18%Net margin, FY2024: -474.60%Net margin, FY2025: -285.20%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 21.47%. Gross margin FY2022 -8.53%. Gross margin FY2023 -10.35%. Gross margin FY2024 13.15%. Gross margin FY2025 21.32%. Operating margin FY2021 -464.05%. Operating margin FY2022 -845.22%. Operating margin FY2023 -594.85%. Operating margin FY2024 -484.20%. Operating margin FY2025 -319.16%. Net margin FY2021 -469.76%. Net margin FY2022 -861.16%. Net margin FY2023 -578.18%. Net margin FY2024 -474.60%. Net margin FY2025 -285.20%.

Income trends

Revenue

2.66M USD+62.65%

Operating income

−8.49M USD-7.21%

Net income

−7.59M USD+2.26%
Income trends across reported periods3.78M USD−685.32K USD−5.15M USD−9.61M USDRevenue, FY2021: 690.67K USDRevenue, FY2022: 659.79K USDRevenue, FY2023: 1.15M USDRevenue, FY2024: 1.64M USDRevenue, FY2025: 2.66M USDOperating income, FY2021: −3.21M USDOperating income, FY2022: −5.58M USDOperating income, FY2023: −6.86M USDOperating income, FY2024: −7.92M USDOperating income, FY2025: −8.49M USDNet income, FY2021: −3.24M USDNet income, FY2022: −5.68M USDNet income, FY2023: −6.66M USDNet income, FY2024: −7.77M USDNet income, FY2025: −7.59M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 690.67K USD. Revenue FY2022 659.79K USD. Revenue FY2023 1.15M USD. Revenue FY2024 1.64M USD. Revenue FY2025 2.66M USD. Operating income FY2021 −3.21M USD. Operating income FY2022 −5.58M USD. Operating income FY2023 −6.86M USD. Operating income FY2024 −7.92M USD. Operating income FY2025 −8.49M USD. Net income FY2021 −3.24M USD. Net income FY2022 −5.68M USD. Net income FY2023 −6.66M USD. Net income FY2024 −7.77M USD. Net income FY2025 −7.59M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.66M USD1.64M USD1.15M USD659.79K USD690.67K USD
Cost of goods sold2.09M USD1.42M USD1.27M USD716.08K USD542.42K USD
Gross profit567.45K USD215.19K USD−119.33K USD−56.29K USD148.25K USD
Research and development725.39M USD819.39K USD662.18K USD524.69K USD86.26K USD
Selling, general, and administrative2.25B USD7.18M USD5.93M USD4.86M USD3.16M USD
Operating expenses9.06M USD8.14M USD6.74M USD5.52M USD3.35M USD
Interest expense——3.04K USD105.17K USD39.43K USD
Depreciation and amortization135.34K USD149.39K USD85.26K USD32.57K USD7.68K USD
Operating income−8.49M USD−7.92M USD−6.86M USD−5.58M USD−3.21M USD
Net income−7.59M USD−7.77M USD−6.66M USD−5.68M USD−3.24M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
73%
8 beats, 3 misses, 0 met estimates
Average EPS surprise
-369.76%
11 comparable reports
Latest EPS result
-0.26
Estimate -0.37 · Beat by 29.73%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.22-0.58-0.94-1.3Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 24, 2025: actual -0.41, estimate -1.22, surprise +66.39%, Beat. Q2 2025, reported May 13, 2025: actual -0.72, estimate -0.73, surprise +1.37%, Beat. Q3 2025, reported Aug 14, 2025: actual -0.66, estimate -0.77, surprise +14.29%, Beat. Q4 2025, reported Nov 13, 2025: actual -0.38, estimate -0.49, surprise +22.45%, Beat. Q1 2026, reported Mar 25, 2026: actual -0.28, estimate -0.43, surprise +34.88%, Beat. Q2 2026, reported May 14, 2026: actual -0.37, estimate -0.47, surprise +21.28%, Beat. Q3 2026, reported Aug 14, 2026: actual -0.26, estimate -0.37, surprise +29.73%, Beat. Q4 2026, reported Nov 12, 2026: actual —, estimate -0.35, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates2.12M1.54M965.43K386.33KQ1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 24, 2025: actual 690.69K USD, estimate 700K USD, surprise -1.33%, Miss. Q2 2025, reported May 13, 2025: actual 454.5K USD, estimate 1M USD, surprise -54.55%, Miss. Q3 2025, reported Aug 14, 2025: actual 579.23K USD, estimate 1M USD, surprise -42.08%, Miss. Q4 2025, reported Nov 13, 2025: actual 668.13K USD, estimate 1M USD, surprise -33.19%, Miss. Q1 2026, reported Mar 25, 2026: actual 959.81K USD, estimate 1.2M USD, surprise -20.02%, Miss. Q2 2026, reported May 14, 2026: actual 773.56K USD, estimate 700K USD, surprise +10.51%, Beat. Q3 2026, reported Aug 14, 2026: actual 1.01M USD, estimate 900K USD, surprise +12.28%, Beat. Q4 2026, reported Nov 12, 2026: actual —, estimate 2M USD, surprise —, Comparison unavailable.

LUCY news

prnewswire.com

Innovative Eyewear, Inc. Announces Major New AI and News Features for Lucyd App

MIAMI, Aug. 20, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie…

Read source
prnewswire.com

Innovative Eyewear Inc. Reports Record Second Quarter 2026 Results

Y-O-Y Second Quarter Revenue Increased 74% & Gross Margin Improved to 24% MIAMI, Aug. 14, 2026 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ: LUCY, LUCYW), ("Innovative Eyewear" or the "Company") the developer of…

Read source
prnewswire.com

Innovative Eyewear, Inc. to Present at Sidoti's Micro-Cap Virtual Investor Conference on August 19

MIAMI, Aug. 14, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. (Nasdaq: LUCY) ("Innovative Eyewear" or the "Company"), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer®,…

Read source
prnewswire.com

Innovative Eyewear, Inc. Announces New Claude AI Integration for All Lucyd Smart Eyewear

MIAMI, July 10, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie…

Read source
gurufocus.com

Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds

Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds PR Newswire

Read source
prnewswire.com

Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds

MIAMI, July 8, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY ), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer® and Nautica®…

Read source

LUCY peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

Continue in GoAI

Research LUCY

research.disclaimer